Optimizing Screening for Acute Human Immunodeficiency Virus Infection with Pooled Nucleic Acid Amplification Tests

ABSTRACT Recent studies have shown the public health importance of identifying individuals with acute human immunodeficiency virus infection (AHI); however, the cost of nucleic acid amplification testing (NAAT) makes individual testing of at-risk individuals prohibitively expensive in many settings. Pooled NAAT (or group testing) can improve efficiency and test performance of testing for AHI, but optimizing the pooling algorithm can be difficult. We developed simple, flexible biostatistical models of specimen pooling with NAAT for the identification of AHI cases; these models incorporate group testing theory, operating characteristics of biological assays, and a model of viral dynamics during AHI. Pooling algorithm sensitivity, efficiency (test kits used per individual specimen evaluated), and positive predictive value (PPV) were modeled and compared for three simple pooling algorithms: two-stage minipools (D2), three-stage hierarchical pools (D3), and square arrays with master pools (A2m). We confirmed the results by stochastic simulation and produced reference tables and a Web calculator to facilitate pooling by investigators without specific biostatistical expertise. All three pooling strategies demonstrated improved efficiency and PPV for AHI case detection compared to individual NAAT. D3 and A2m algorithms generally provided better efficiency and PPV than D2; additionally, A2m generally exhibited better PPV than D3. Used selectively and carefully, the simple models developed here can guide the selection of a pooling algorithm for the detection of AHI cases in a wide variety of settings.

[1]  Douglas D. Richman,et al.  Viral Dynamics of Acute HIV-1 Infection , 1999, The Journal of experimental medicine.

[2]  Anatoly Zhigljavsky,et al.  COMPARISON OF COSTS FOR MULTI-STAGE GROUP TESTING METHODS IN THE PHARMACEUTICAL INDUSTRY , 2001 .

[3]  Cheryl Jennings,et al.  HIV-1 Viral Load Assays for Resource-Limited Settings , 2006, PLoS medicine.

[4]  T. Quinn,et al.  Successful use of pooled sera to determine HIV-1 seroprevalence in Zaire with development of cost-efficiency models. , 1990, AIDS.

[5]  J. Klausner The NAAT is out of the bag. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  K. Nishioka,et al.  High throughput screening of 16 million serologically negative blood donors for hepatitis B virus, hepatitis C virus and human immunodeficiency virus type-1 by nucleic acid amplification testing with specific and sensitive multiplex reagent in Japan. , 2003, Journal of virological methods.

[7]  H. Doerr,et al.  Evaluation of a New Combined Antigen and Antibody Human Immunodeficiency Virus Screening Assay, VIDAS HIV DUO Ultra , 2002, Journal of Clinical Microbiology.

[8]  Richard R. Carlson Inspection Errors for Attributes in Quality Control , 1993 .

[9]  Jack K. Wolf,et al.  Born again group testing: Multiaccess communications , 1985, IEEE Trans. Inf. Theory.

[10]  H. M. Finucan The Blood Testing Problem , 1964 .

[11]  J L Gastwirth,et al.  The efficiency of pooling in the detection of rare mutations. , 2000, American journal of human genetics.

[12]  William C Miller,et al.  Frequent detection of acute primary HIV infection in men in Malawi , 2004, AIDS.

[13]  William C Miller,et al.  Detection of acute infections during HIV testing in North Carolina. , 2005, The New England journal of medicine.

[14]  G. Hill,et al.  Mosquito and Arbovirus Activity During 1997–2002 in a Wetland in Northeastern Mississippi , 2004, Journal of medical entomology.

[15]  Michael P Busch,et al.  Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection , 2003, AIDS.

[16]  M. Golden,et al.  Targeted screening for primary HIV infection through pooled HIV-RNA testing in men who have sex with men , 2005, AIDS.

[17]  H C Tuckwell,et al.  Direct HIV testing in blood donations: variation of the yield with detection threshold and pool size , 1999, Transfusion.

[18]  R. Venette,et al.  Strategies and statistics of sampling for rare individuals. , 2002, Annual review of entomology.

[19]  Hae-Young Kim Operating characteristics of group testing algorithms for case identification in the presence of test error , 2007 .

[20]  Christopher D Pilcher,et al.  Real-time, universal screening for acute HIV infection in a routine HIV counseling and testing population. , 2002, JAMA.

[21]  D. Gupta,et al.  Group testing in presence of classification errors. , 1999, Statistics in medicine.

[22]  C. Kent,et al.  Detection of acute HIV infections. , 2005, The New England journal of medicine.

[23]  Hae-Young Kim,et al.  Comparison of Group Testing Algorithms for Case Identification in the Presence of Test Error , 2007, Biometrics.

[24]  M. Vatteroni,et al.  HIV‐1 NAT minipool during the pre‐seroconversion window period: detection of a repeat blood donor , 2006, Vox sanguinis.

[25]  Marcello Pagano,et al.  Screening for the Presence of a Disease by Pooling Sera Samples , 1994 .

[26]  Minge Xie,et al.  Group Testing With Blockers and Synergism , 2001 .

[27]  W. Miller,et al.  Rapid, real-time detection of acute HIV infection in patients in Africa. , 2007, The Journal of infectious diseases.

[28]  R. Phatarfod,et al.  The use of a square array scheme in blood testing. , 1994, Statistics in medicine.

[29]  F. Hecht,et al.  Quantitative and Cost Comparison of Ultrasensitive Human Immunodeficiency Virus Type 1 RNA Viral Load Assays: Bayer bDNA Quantiplex Versions 3.0 and 2.0 and Roche PCR Amplicor Monitor Version 1.5 , 2000, Journal of Clinical Microbiology.

[30]  C. Woodbury,et al.  Sample multiplexing for greater throughput in HPLC and related methods. , 1995, Analytical chemistry.

[31]  R. Dorfman The Detection of Defective Members of Large Populations , 1943 .

[32]  S. Yerly,et al.  Detection of Human Immunodeficiency Virus Type 1 (HIV-1) RNA in Pools of Sera Negative for Antibodies to HIV-1 and HIV-2 , 1998, Journal of Clinical Microbiology.

[33]  R Brookmeyer,et al.  Feasibility of pooling sera for HIV-1 viral RNA to diagnose acute primary HIV-1 infection and estimate HIV incidence , 2000, AIDS.

[34]  T. Quinn,et al.  Determinations of Levels of Human Immunodeficiency Virus Type 1 RNA in Plasma: Reassessment of Parameters Affecting Assay Outcome , 1998, Journal of Clinical Microbiology.

[35]  J. Mandell,et al.  Maximally Efficient Two‐Stage Screening , 2000, Biometrics.